Olema Pharmaceuticals
Latest round
- Series C
Last raised
- Sep 2020
Total raised
- $141M
Investors
- 15
About Olema Pharmaceuticals
Olema Pharmaceuticals, Inc.Founded in 2007, Olema Pharmaceuticals, Inc. operates from San Francisco, US, and specializes in oncology.Olema Pharmaceuticals primarily develops innovative therapies for breast cancer, exemplified by their lead candidate, Palazestrant (OP-1250). This once-daily oral treatment targets advanced estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer in patients facing disease progression after prior treatments.Olema Pharmaceuticals generates revenue through partnerships and collaborations within the oncology sector. Their business model involves direct agreements with healthcare institutions and pharmaceutical distributors, facilitating access to their therapies.00 mn by selling 11 million shares at USD 19 per share on Nasdaq in November 2020. The company is also focused on entering new markets, including additional regions in Europe and Asia, by 2024, thus enhancing their global footprint.
Who invested in Olema Pharmaceuticals
15 investors across 2 rounds
See all investors in Olema Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Olema Pharmaceuticals
Who invested in Olema Pharmaceuticals?
Olema Pharmaceuticals has 15 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Olema Pharmaceuticals raised?
Olema Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Olema Pharmaceuticals last raise money?
Olema Pharmaceuticals's most recent round on record is a Series C, in Sep 2020.
What does Olema Pharmaceuticals do?
Olema Pharmaceuticals is a biotechnology company.
Where is Olema Pharmaceuticals headquartered?
Olema Pharmaceuticals is headquartered in San Francisco, US.
Which VCs invest in companies like Olema Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Olema Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Olema Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.